[ORGANIZATION]
Opdivo
Featured in 2 tracked stories · first seen
Situations
Replimune melanoma therapy FDA approval
3 clusters · 18 sources · last updated
Latest: FDA approves new oncolytic viral therapy for anti‑PD‑1‑refractory melanoma
Following the FDA’s Cellular, Tissue and Gene Therapies Advisory Committee vote of 10‑3 in late July 2026, the agency granted accelerated approval on 6 August 2026 to Replimune’s oncolytic herpes‑virus therapy RP1, marke
AstraZeneca–Bristol Myers merger talks
3 clusters · 69 sources · last updated
Latest: AstraZeneca and Bristol Myers Squibb Merger Talks Dismissed
In early August 2026 AstraZeneca and Bristol Myers Squibb were reported to be in talks about a $400 billion merger, prompting a 9 % drop in AstraZeneca’s share price and speculation about a possible headquarters move to